Research suggests that certain medications, including semaglutide and tirzepatide, may help reduce alcohol consumption in individuals with obesity. These medications, known as GLP-1 receptor agonists, are typically used to treat obesity and type 2 diabetes, but may also have an effect on alcohol use disorder. The potential relationship between these medications and reduced alcohol consumption is being explored in various studies and reviews.